Pluri Biotech (פלורי ביוטק בע"מ, formerly Pluristem Therapeutics) is a clinical-stage biotherapy company developing cell therapies. It uses placental cells and a three-dimensional technology platform to treat conditions such as inflammation, ischemia, muscle injuries, hematological disorders, and exposure to radiation.